CBAV Share Price Performance
€57.20
12.60 (28.25%)
36.9% undervalued intrinsic discount
€90.72
Fair Value
Price €57.20
Imthetxarbi €90.72
Khalid06 €69.00
Fair Value€90.72
Share Pricen/a
New Narrative • Jun 05
Clínica Baviera, S.A. Stock Price
- 2 Narratives written by author
- 0 Comments on narratives written by author
- 35 Fair Values set on narratives written by author
CBAV Community Narratives
IM
Fair Value
·Fair Value €90.72 36.9% undervalued intrinsic discount
Baviera: A 40% ROCE Compounding Machine Trading at Distressed Multiples — Fair Value €88/share
1users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
KH
Fair Value
·Fair Value €69 17.1% undervalued intrinsic discount
The Undervaluation of Clinica Baviera: An Opportunity for Investors?
2users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
Baviera: A 40% ROCE Compounding Machine Trading at Distressed Multiples — Fair Value €88/share
Clínica Baviera runs eye-care clinics across Europe, and its newest clinics tend to pay back quickly while the core business keeps growing through repeat referrals and a strong brand. The big question is whether the market is missing how resilient this model can be even as Germany and the UK face short-term pressure.Read more
IM
€90.72
36.9% undervalued intrinsic discount
Fair Value
Revenue
15.4% p.a.
Profit Margin
17%
Future PE
18x
Price in 2031
€129.17
The Undervaluation of Clinica Baviera: An Opportunity for Investors?
A steady eye-care business throws off a lot of cash, yet the market may be overlooking it. The big question is whether paying out so much to shareholders slows its growth less than people fear.Read more
KH
€69
17.1% undervalued intrinsic discount
Fair Value
Revenue
13.2% p.a.
Profit Margin
14.68%
Future PE
13.54x
Price in 2034
€131.93
Trending Discussion
No trending discussion available.
Recently Updated Narratives
IM
Baviera: A 40% ROCE Compounding Machine Trading at Distressed Multiples — Fair Value €88/share
Fair Value: €90.72 36.9% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
KH
The Undervaluation of Clinica Baviera: An Opportunity for Investors?
Fair Value: €69 17.1% undervalued intrinsic discount
5 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Proven track record with adequate balance sheet and pays a dividend.
1 Risk
2 Rewards
Clínica Baviera, S.A. Key Details
About CBAV
- Founded
- 1992
- Employees
- 1592
- CEO
- WebsiteView website
Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pediatric ophthalmology, glaucoma, neuro-ophthalmological, disorders, and blepharoplasty treatments. It also provides external and internal consultations, surgery treatments, and rehabilitation services. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínica Baviera, S.A. in 2000. Clínica Baviera, S.A. was incorporated in 1992 and is based in Madrid, Spain. Clínica Baviera, S.A. is a subsidiary of Aier Eye International (Europe), S.L.U.
